EUVIMEDEUVIMED entdecken
Open Access

Effect analysis of entecavir on serum hyaluronic acid, laminin and IV collagen in the treatment of hepatitis B E-antigen-positive chronic hepatitis B

Jiancheng Qian, Xiaoyong Sun, Yue Cheng

African Health Sciences · 2025

DOI: 10.4314/ahs.v24i4.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Health Sciences, 2025. Verfasst von Jiancheng Qian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Tongde Hospital of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Hyaluronic Acid, Hepatitis B, Chronic, Guanine, Antiviral Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To observe and analyse the clinical effects of entecavir on serum hyaluronic acid (HA), laminin (LN), and type IV collagen (IVC) in patients with hepatitis B e-antigen (HBeAG)-positive chronic hepatitis B during clinical treatment. Methodology: The patients in the control group received clinical treatment with entecavir monotherapy, while those in the observation group underwent thymalfasin + entecavir combination therapy. The clinical curative effects of immune checkpoint inhibitors at different concentrations on diseases were compared from all aspects.

Results

There were lower levels of total bilirubin (TBIL) and alanine transaminase (ALT) in the observation group, a more satisfactory improvement in immune function-related indicators, and lower levels of HA, LN, and IVC in the observation group, which were statistically different between the two groups (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidHepatitis B, ChronicGuanineAntiviral AgentsHepatitis B e AntigensCollagen Type IVLamininHumansFemaleMaleAdultMiddle AgedDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

Entecavirclinical outcome analysise antigen-positive chronic hepatitis Blaminin (LN)serum hyaluronic acid (HA)type IV collagen (IVC)

Substanzen

entecavirHyaluronic AcidGuanineAntiviral AgentsHepatitis B e AntigensCollagen Type IVLaminin

Autor:innen und Institutionen

  • Department of Infectious Disease, Tongde Hospital of Zhejiang Province, Hangzhou, China.
  • Department of Infectious Disease, Xinchang County People's Hospital, Shaoxing, China.
  • Laboratory Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China.

Zitieren

APA

Qian, J., Sun, X., & Cheng, Y. (2025). Effect analysis of entecavir on serum hyaluronic acid, laminin and IV collagen in the treatment of hepatitis B E-antigen-positive chronic hepatitis B. African Health Sciences. https://doi.org/10.4314/ahs.v24i4.6

Vancouver

Qian J, Sun X, Cheng Y. Effect analysis of entecavir on serum hyaluronic acid, laminin and IV collagen in the treatment of hepatitis B E-antigen-positive chronic hepatitis B. African Health Sciences. 2025. doi:10.4314/ahs.v24i4.6

BibTeX
@article{Qian2025,
  author = {Qian, Jiancheng and Sun, Xiaoyong and Cheng, Yue},
  title = {Effect analysis of entecavir on serum hyaluronic acid, laminin and IV collagen in the treatment of hepatitis B E-antigen-positive chronic hepatitis B},
  journal = {African Health Sciences},
  year = {2025},
  doi = {10.4314/ahs.v24i4.6}
}
Kostenlos starten →